Back
Amicus Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
48
FOLD
Amicus Therapeutics
Last Price:
11.21
Seasonality Move:
-7.74%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.16 | Sell |
| 20-day SMA: | 11.4 | Sell |
| 50-day SMA: | 11 | Sell |
| 200-day SMA: | 11.43 | Sell |
| 8-day EMA: | 11.16 | Sell |
| 20-day EMA: | 11.27 | Sell |
| 50-day EMA: | 11.06 | Sell |
| 200-day EMA: | 11.15 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 44.2 | Sell |
| Chaikin Money Flow: | -1671939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.18 - 11.76) | Sell |
| Bollinger Bands (100): | (9.74 - 11.22) | Buy |
Amicus Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 11.00 while FOLD 8-day simple moving average is 11.16, which is a Sell signal.
- The stock price of FOLD is 11.00 while Amicus Therapeutics 20-day SMA is 11.40, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 11.00 while FOLD share price is 11.00, making it a Sell technically.
- FOLD stock price is 11.00 and Amicus Therapeutics 200-day simple moving average is 11.43, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
48
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $11.00. The Score for FOLD is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
3.26B
Price in USD:
11.00
Share Volume:
2.25M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
48
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 11.00 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 11.00 while FOLD 8-day exponential moving average is 11.16, which is a Sell signal.
- The stock price of FOLD is 11.00 while Amicus Therapeutics 20-day EMA is 11.27, which makes it a Sell.
- Amicus Therapeutics 50-day exponential moving average is 11.06 while FOLD share price is 11.00, making it a Sell technically.
- FOLD stock price is 11.00 and Amicus Therapeutics 200-day simple moving average is 11.15, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.29 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 44.2, which suggest Amicus Therapeutics is oversold
- The Bollinger Bands (25) for Amicus Therapeutics is (11.18 - 11.76), which suggest Amicus Therapeutics is a Buy
- The Bollinger Bands (100) for Amicus Therapeutics is (9.74 - 11.22), which suggest Amicus Therapeutics is a Buy
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.